Range Low Price High Price Comment
30 days $0.277 $0.277 Friday, 22nd Sep 2023 ONCS stock ended at $0.277. During the day the stock fluctuated 0% from a day low at $0.277 to a day high of $0.277.
90 days $0.277 $0.277
52 weeks $0.180 $6.50

Historical OncoSec Medical Incorporated prices

Date Open High Low Close Volume
2023-09-22 $0.277 $0.277 $0.277 $0.277 0
2023-09-20 $0.277 $0.277 $0.277 $0.277 0
2023-09-19 $0.277 $0.277 $0.277 $0.277 0
2023-09-18 $0.277 $0.277 $0.277 $0.277 0
2023-09-15 $0.277 $0.277 $0.277 $0.277 0
2023-09-14 $0.277 $0.277 $0.277 $0.277 0
2023-09-13 $0.277 $0.277 $0.277 $0.277 0
2023-09-12 $0.277 $0.277 $0.277 $0.277 0
2023-09-11 $0.277 $0.277 $0.277 $0.277 0
2023-09-08 $0.277 $0.277 $0.277 $0.277 0
2023-09-07 $0.277 $0.277 $0.277 $0.277 0
2023-09-06 $0.277 $0.277 $0.277 $0.277 0
2023-09-05 $0.277 $0.277 $0.277 $0.277 0
2023-09-01 $0.277 $0.277 $0.277 $0.277 0
2023-08-31 $0.277 $0.277 $0.277 $0.277 0
2023-08-30 $0.277 $0.277 $0.277 $0.277 0
2023-08-29 $0.277 $0.277 $0.277 $0.277 0
2023-08-28 $0.277 $0.277 $0.277 $0.277 0
2023-08-25 $0.277 $0.277 $0.277 $0.277 0
2023-08-24 $0.277 $0.277 $0.277 $0.277 0
2023-08-23 $0.277 $0.277 $0.277 $0.277 0
2023-08-22 $0.277 $0.277 $0.277 $0.277 0
2023-08-21 $0.277 $0.277 $0.277 $0.277 0
2023-08-18 $0.277 $0.277 $0.277 $0.277 0
2023-08-17 $0.277 $0.277 $0.277 $0.277 0
Click to get the best stock tips daily for free!

About OncoSec Medical Incorporated

OncoSec Medicalorporated OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is a... ONCS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT